Zevenbergen Capital Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-327,645
| Closed | -$27.3M | – | 81 |
|
2016
Q2 | $27.3M | Sell |
327,645
-72,400
| -18% | -$6.04M | 1.28% | 32 |
|
2016
Q1 | $36.7M | Sell |
400,045
-125,845
| -24% | -$11.6M | 1.66% | 25 |
|
2015
Q4 | $53.2M | Sell |
525,890
-58,055
| -10% | -$5.87M | 2.16% | 21 |
|
2015
Q3 | $57.3M | Sell |
583,945
-4,195
| -0.7% | -$412K | 2.46% | 17 |
|
2015
Q2 | $68.9M | Sell |
588,140
-67,850
| -10% | -$7.94M | 2.68% | 14 |
|
2015
Q1 | $64.4M | Sell |
655,990
-63,960
| -9% | -$6.28M | 2.69% | 15 |
|
2014
Q4 | $67.9M | Buy |
719,950
+1,400
| +0.2% | +$132K | 2.94% | 14 |
|
2014
Q3 | $76.5M | Sell |
718,550
-305,170
| -30% | -$32.5M | 3.27% | 12 |
|
2014
Q2 | $84.9M | Buy |
1,023,720
+56,395
| +6% | +$4.68M | 2.98% | 11 |
|
2014
Q1 | $68.5M | Buy |
967,325
+205,640
| +27% | +$14.6M | 2.45% | 16 |
|
2013
Q4 | $57.2M | Buy |
+761,685
| New | +$57.2M | 1.97% | 23 |
|